Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of NHE1 Overcomes Temozolomide-Resistance in Glioblastoma via ROS-AKT/ERK Axis-Mediated Autophagy Suppression. | J Biochem Mol Toxicol | 2026 | 42740476 | PubTator, text mining | PubMed |
| Macrophage Dab1 Links Early Hypoxia to Adaptive Angiogenesis to Drive Peripheral Nerve Repair. | Adv Sci (Weinh) | 2026 | 42723198 | PubTator, text mining | PubMed |
| Cardiomyocyte calcium homeostasis remodeling in diabetes-related HFpEF: mechanisms and therapeutic perspectives. | Pharmacol Res | 2026 | 42697419 | PubTator, text mining | PubMed |
| Revising NHE-1: From Cardiac Homeostasis to Heart Failure and Future Drug Development. | Cell Biochem Funct | 2026 | 42677384 | PubTator, text mining | PubMed |
| NHE1 in Gastrointestinal Inflammation and Cancer: A Double-Edged Regulator. | Dig Dis Sci | 2026 | 42635895 | PubTator, text mining | PubMed |
| Genetically predicted triglyceride levels and endometriosis risk: Mendelian randomization with exploratory multi-omics analyses. | PLoS One | 2026 | 42594068 | PubTator, text mining | PubMed |
| CD44-targeting small-molecule inhibitors restore hyaluronan homeostasis and reduce profibrotic matrix remodeling in vocal fold fibroblasts exposed to cigarette smoke extract. | Toxicology | 2026 | 42562202 | PubTator, text mining | PubMed |
| Recent progress in small molecules targeting the acidic tumor microenvironment. | J Enzyme Inhib Med Chem | 2026 | 42550763 | PubTator, text mining | PubMed |
| Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring. | Pharmacol Ther | 2026 | 42492739 | PubTator, text mining | PubMed |
| DLK1-35 Contributes to Temozolomide Resistance in Glioblastoma Through the miR-140-3p/NHE1/ERK-MGMT Axis. | Tohoku J Exp Med | 2026 | 42486642 | PubTator, text mining | PubMed |
| Revealing the Regulatory Interplay of NHE1 mRNA and Na+ in Cancer Cells Using a DNA Nanosensor. | Anal Chem | 2026 | 42406465 | PubTator, text mining | PubMed |
| Inhibition of NHE1 induces trophoblast cell senescence via ADGRG6 mediated by CXCL8. | J Reprod Immunol | 2026 | 42364290 | PubTator, text mining | PubMed |
| NF-κB signaling pathway mediates the anti-tumor effect of Ginsenoside Rg1 in glioblastoma. | Biochem Biophys Rep | 2026 | 42328155 | PubTator, text mining | PubMed |
| Effects of obacunone against myocardial fibrosis: Mechanistic insights from network pharmacology and experimental validation. | Eur J Pharmacol | 2026 | 42214778 | PubTator, text mining | PubMed |
| Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry. | Cells | 2026 | 42193876 | PubTator, text mining | PubMed |
| A Propionate Metabolism-Based Gene Signature Reveals Immunogenomic and Transcriptomic Determinants of Prognosis in Glioblastoma Through Multiomics Integration. | Hum Mutat | 2026 | 42147808 | PubTator, text mining | PubMed |
| SGLT2 Inhibition as a Perioperative Cardiorenal Stabilizer in Cardiac Surgery: Integrated Clinical Cohort and Pleiotropic Network-Based Pharmacological Analysis. | J Clin Med | 2026 | 42074676 | PubTator, text mining | PubMed |
| A Hidden Checkpoint: Bidirectional pH Remodeling of the Immunological Synapse in Cancer, Methods, and Therapeutic Opportunities. | J Immunol Res | 2026 | 42054667 | PubTator, text mining | PubMed |
| From molecular mechanisms of glycosphingolipid function to bio-therapeutic applications. | Cell Mol Life Sci | 2026 | 41904721 | PubTator, text mining | PubMed |
| NHE1-Mediated Metabolic Reprogramming in Cancer. | Metabolites | 2026 | 41893344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers